# Sam Altman Net Worth 2026: His $3.3B Portfolio Across Helion, Worldcoin, and Retro Biosciences _OpenAI closed a $122 billion funding round at an $852 billion valuation in March 2026. Here is a company-by-company breakdown of every venture Sam Altman controls or has materially funded, from Helion Energy at $15.5 billion to Retro Biosciences at $1.8 billion._ **Published:** 2026-07-26 **Source:** https://www.startuphub.ai/ai-news/ai-figures/2026/figure-sam-altman-venture-portfolio-breakdown-2026-07-26 --- **Sam Altman's net worth in 2026 reaches an estimated $3.3 billion, built entirely through ventures outside OpenAI: he holds no equity in the company he leads. OpenAI closed a $122 billion funding round at an $852 billion valuation in March 2026, per [Forbes](https://www.forbes.com/sites/antoniopequenoiv/2026/03/31/openai-valuation-reaches-852-billion-after-massive-funding-round/), but Altman's personal capital footprint spans four distinct ventures in fusion energy, biometric identity, and longevity science, each at a different stage of the risk curve.** Quick context Sam Altman, 41, is CEO of OpenAI and executive chairman of Helion Energy. He previously served as president of Y Combinator from 2014 to 2019. This portfolio breakdown covers every venture in which Altman holds a material ownership or executive role, drawing on publicly sourced valuations and funding disclosures as of July 2026. ## OpenAI: $20B ARR and the Countdown to a 2027 IPO OpenAI's annualized revenue run rate reached $20 billion by the end of 2025, up from roughly $6 billion the year prior, according to statements from CEO Sam Altman and CFO Sarah Friar reported by [Yahoo Finance](https://finance.yahoo.com/news/sam-altman-says-openai-20b-211806316.html). The company's internal projections, reported by [Fortune](https://fortune.com/2026/02/20/openai-revenue-forecast-280-billion-2030-capex-sam-altman/) in February 2026, target $280 billion in annual revenue by 2030. The capital structure underpinning that growth is substantial. OpenAI's $122 billion March round was co-led by SoftBank alongside Andreessen Horowitz, D.E. Shaw, Nvidia, and Amazon, per Forbes. That brings total committed data center investment to approximately $1.4 trillion over eight years, a figure Altman himself cited publicly. The company completed its for-profit restructuring in October 2025, converting to OpenAI Group PBC while keeping the nonprofit OpenAI Foundation as a major equity holder. OpenAI filed a confidential S-1 on June 8, 2026, but is now targeting a 2027 IPO, according to [Bloomberg](https://www.bloomberg.com/news/articles/2026-07-02/openai-proposes-giving-the-us-government-a-5-stake-ft-says). That same Bloomberg report noted OpenAI proposed offering a 5 percent equity stake to the US government as part of a broader regulatory arrangement. One outstanding question concerns Altman's personal stake. OpenAI had discussed granting him approximately 7 percent equity as part of the for-profit conversion, per Bloomberg's 2024 reporting, though Altman publicly said at the time that no such plan was finalized. The S-1 filing will settle the question. For more on how the broader market views OpenAI's capital structure, see [SoftBank's $65B OpenAI Bet Sparks Investor Concern](https://www.startuphub.ai/ai-news/softbank-s-65b-openai-bet-sparks-investor-concern). ![](https://quickchart.io/chart?w=700&h=350&c=%7B%22type%22%3A%22bar%22%2C%22data%22%3A%7B%22labels%22%3A%5B%222023%22%2C%222024%22%2C%222025%22%5D%2C%22datasets%22%3A%5B%7B%22label%22%3A%22ARR%20%28%24B%29%22%2C%22data%22%3A%5B2%2C6%2C20%5D%2C%22backgroundColor%22%3A%5B%22%23818cf8%22%2C%22%236366f1%22%2C%22%234f46e5%22%5D%7D%5D%7D%2C%22options%22%3A%7B%22plugins%22%3A%7B%22title%22%3A%7B%22display%22%3Atrue%2C%22text%22%3A%22OpenAI%20Annualized%20Revenue%20Run%20Rate%20%28%24B%29%22%7D%2C%22legend%22%3A%7B%22display%22%3Afalse%7D%7D%2C%22scales%22%3A%7B%22y%22%3A%7B%22beginAtZero%22%3Atrue%7D%7D%7D%7D) OpenAI ARR, 2023-2025. Sources: [Yahoo Finance](https://finance.yahoo.com/news/sam-altman-says-openai-20b-211806316.html); [Fortune](https://fortune.com/2026/02/20/openai-revenue-forecast-280-billion-2030-capex-sam-altman/). ## Helion Energy: Altman Owns a Third of a $15.5B Fusion Startup Helion Energy raised $465 million in June 2026 at a post-money valuation of $15.5 billion, per reporting from [TechCrunch](https://techcrunch.com/2026/06/04/helion-the-sam-altman-backed-fusion-startup-raises-465m-to-build-a-power-plant-for-microsoft/) and [GeekWire](https://www.geekwire.com/2026/helion-hits-15-5b-valuation-with-465m-in-new-cash-to-commercialize-fusion-this-decade/), bringing total capital raised above $1.5 billion. The round more than tripled the company's valuation from $5.4 billion in January 2025, when it closed a $425 million Series F. Altman's ownership position became public during litigation. Court disclosures from the Musk v. Altman trial revealed that he holds roughly one-third of Helion, where he serves as executive chairman. At the June 2026 valuation, that implies a stake worth approximately $5 billion on paper. The company's stated objective is to deliver fusion-generated electricity to Microsoft's grid by 2028, per the TechCrunch report. Microsoft's power-purchase agreement with Helion, first announced in 2023, remains the central commercial milestone the company is racing to meet. Fusion energy has a decades-long history of missed deadlines, but Helion's approach, which uses helium-3 as fuel and recovers energy from a collapsing magnetic field, is distinct from the tokamak designs pursued by ITER and Commonwealth Fusion Systems. Whether the 2028 target holds will be tested over the next 18 months as the company moves from its seventh-generation Polaris device into engineering for the actual power plant. ![](https://quickchart.io/chart?w=700&h=350&c=%7B%22type%22%3A%22bar%22%2C%22data%22%3A%7B%22labels%22%3A%5B%22Jan%202025%20%28Series%20F%29%22%2C%22Jun%202026%22%5D%2C%22datasets%22%3A%5B%7B%22label%22%3A%22Valuation%20%28%24B%29%22%2C%22data%22%3A%5B5.4%2C15.5%5D%2C%22backgroundColor%22%3A%5B%22%23a78bfa%22%2C%22%237c3aed%22%5D%7D%5D%7D%2C%22options%22%3A%7B%22plugins%22%3A%7B%22title%22%3A%7B%22display%22%3Atrue%2C%22text%22%3A%22Helion%20Energy%20Valuation%20%28%24B%29%22%7D%2C%22legend%22%3A%7B%22display%22%3Afalse%7D%7D%2C%22scales%22%3A%7B%22y%22%3A%7B%22beginAtZero%22%3Atrue%7D%7D%7D%7D) Helion Energy valuation at last two disclosed rounds. Sources: [TechCrunch](https://techcrunch.com/2026/06/04/helion-the-sam-altman-backed-fusion-startup-raises-465m-to-build-a-power-plant-for-microsoft/); [GeekWire](https://www.geekwire.com/2026/helion-hits-15-5b-valuation-with-465m-in-new-cash-to-commercialize-fusion-this-decade/). ## World and Retro Biosciences: Identity Infrastructure and the Longevity Science Bet World, formerly known as Worldcoin, raised $52.5 million through a strategic crypto token sale on July 24, 2026, per [TechCrunch](https://techcrunch.com/2026/07/24/sam-altmans-biometric-startup-world-raises-52-5-million-via-crypto-sale/). The company, co-founded by Altman, has iris-scanned and verified approximately 17.5 million users using its Orb device, and is repositioning itself as identity infrastructure for the AI era, signing enterprise integrations with Zoom and Docusign. The argument is straightforward: as AI-generated deepfakes proliferate, organizations need a reliable signal that the person on the other side of a video call or document signature is human. World's iris hash provides that signal without transmitting biometric data to third parties. Retro Biosciences sits at an even earlier stage of the risk curve. Altman personally provided the company's entire $180 million seed round in 2023, as reported by [MIT Technology Review](https://www.technologyreview.com/2023/03/08/1069523/sam-altman-investment-180-million-retro-biosciences-longevity-death/). As of May 2026, the company is valued at $1.8 billion, per [STAT News](https://www.statnews.com/2026/05/22/retro-biosciences-longevity-valuation/), having raised a broader funding round. Retro's stated mission is to add ten healthy years to the human lifespan using a combination of AI, in-vivo gene therapies, and cell-replacement approaches. Its first clinical trial, testing a pill targeting protein aggregates in Alzheimer's patients, was described by CEO Joe Betts-LaCroix as going "super good" with no dose-limiting toxicities, per STAT News. ![](https://quickchart.io/chart?w=700&h=350&c=%7B%22type%22%3A%22horizontalBar%22%2C%22data%22%3A%7B%22labels%22%3A%5B%22OpenAI%22%2C%22Helion%20Energy%22%2C%22Retro%20Biosciences%22%5D%2C%22datasets%22%3A%5B%7B%22label%22%3A%22Valuation%20%28%24B%29%22%2C%22data%22%3A%5B852%2C15.5%2C1.8%5D%2C%22backgroundColor%22%3A%5B%22%234f46e5%22%2C%22%237c3aed%22%2C%22%23a78bfa%22%5D%7D%5D%7D%2C%22options%22%3A%7B%22plugins%22%3A%7B%22title%22%3A%7B%22display%22%3Atrue%2C%22text%22%3A%22Sam%20Altman%20Portfolio%3A%20Disclosed%20Valuations%20%28%24B%29%22%7D%2C%22legend%22%3A%7B%22display%22%3Afalse%7D%7D%2C%22scales%22%3A%7B%22x%22%3A%7B%22beginAtZero%22%3Atrue%7D%7D%7D%7D) Disclosed valuations across Altman's material holdings. World valuation excluded (token-based structure). Sources: Forbes; TechCrunch; STAT News. ## What It Means Altman's portfolio is a study in risk concentration across long time horizons. OpenAI is already a commercial business generating $20 billion in annualized revenue and moving toward a public listing. Helion is a capital-intensive hardware bet on a technology that has never been commercialized, with an 18-month runway to its first grid-scale milestone. World is a consumer-facing crypto-adjacent network pivoting to enterprise before it has proven unit economics. Retro is pre-revenue science. What they share is a common premise: that AI will create new categories of human vulnerability, whether in energy supply, identity verification, or longevity, that existing institutions are not equipped to solve. Whether that premise converts into returns is a question the next two to three years will begin to answer. ## Sources - ![](https://www.google.com/s2/favicons?domain=forbes.com&sz=32) [Forbes: OpenAI Valuation Reaches $852 Billion After Massive Funding Round](https://www.forbes.com/sites/antoniopequenoiv/2026/03/31/openai-valuation-reaches-852-billion-after-massive-funding-round/) - ![](https://www.google.com/s2/favicons?domain=yahoo.com&sz=32) [Yahoo Finance: Sam Altman Says OpenAI Has $20B ARR](https://finance.yahoo.com/news/sam-altman-says-openai-20b-211806316.html) - ![](https://www.google.com/s2/favicons?domain=fortune.com&sz=32) [Fortune: OpenAI Revenue Forecast $280 Billion by 2030](https://fortune.com/2026/02/20/openai-revenue-forecast-280-billion-2030-capex-sam-altman/) - ![](https://www.google.com/s2/favicons?domain=bloomberg.com&sz=32) [Bloomberg: OpenAI Proposes Giving the US Government a 5 Percent Stake](https://www.bloomberg.com/news/articles/2026-07-02/openai-proposes-giving-the-us-government-a-5-stake-ft-says) - ![](https://www.google.com/s2/favicons?domain=techcrunch.com&sz=32) [TechCrunch: Helion Raises $465M to Build a Power Plant for Microsoft](https://techcrunch.com/2026/06/04/helion-the-sam-altman-backed-fusion-startup-raises-465m-to-build-a-power-plant-for-microsoft/) - ![](https://www.google.com/s2/favicons?domain=geekwire.com&sz=32) [GeekWire: Helion Hits $15.5B Valuation With $465M in New Cash](https://www.geekwire.com/2026/helion-hits-15-5b-valuation-with-465m-in-new-cash-to-commercialize-fusion-this-decade/) - ![](https://www.google.com/s2/favicons?domain=techcrunch.com&sz=32) [TechCrunch: Sam Altman's Biometric Startup World Raises $52.5M via Crypto Sale](https://techcrunch.com/2026/07/24/sam-altmans-biometric-startup-world-raises-52-5-million-via-crypto-sale/) - ![](https://www.google.com/s2/favicons?domain=technologyreview.com&sz=32) [MIT Technology Review: Sam Altman Invested $180 Million in Retro Biosciences](https://www.technologyreview.com/2023/03/08/1069523/sam-altman-investment-180-million-retro-biosciences-longevity-death/) - ![](https://www.google.com/s2/favicons?domain=statnews.com&sz=32) [STAT News: Retro Biosciences Latest Fundraising Values It at $1.8 Billion](https://www.statnews.com/2026/05/22/retro-biosciences-longevity-valuation/) Editorial standards: every claim is sourced. Tips: editor@startuphub.ai *Last updated: August 2026* ## New Investments and Portfolio Updates Since this breakdown was first published in late July 2026, one significant addition has surfaced in Altman's portfolio orbit. In January 2026, Altman co-founded Merge Labs, a brain-computer interface startup that received a $252 million investment from OpenAI, adding frontier neuroscience to his already unconventional thesis alongside fusion and longevity science. A Fortune interview published August 3, 2026 offered Altman's most detailed account yet of how he approaches personal investing: crediting advice from Peter Thiel and Paul Graham for shaping his preference for highly concentrated, long-horizon bets over diversification, the same philosophy that led him to Helion before fusion was fashionable. StartupHub.ai data shows OpenAI secured a $520 million Sora credit line in July 2026, per Bloomberg, the latest financing move as the company targets a 2027 IPO and expands into video generation as a commercial product layer. ## What Reddit Users Are Saying About OpenAI Across 5 recent discussions in r/technology, r/ChatGPT, and r/OpenAI tracked by StartupHub.ai, sentiment has been sharply split between breakthrough model announcements and safety incidents: > "OpenAI says AI models went rogue during testing, triggering 'unprecedented' breach at startup." (r/news, July 2026) > "OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluation." (r/technology, July 2026) > "OpenAI says it has reached a new threshold in AI, new model capable of breakthrough research." (r/OpenAI, August 2026) For investors assessing the OpenAI stake that sits at the center of this portfolio breakdown, the pattern matters: the July 2026 containment failures and the August breakthrough announcement reflect the dual risk-return profile Altman has navigated since 2015 and will continue to navigate through the 2027 IPO window. ## Frequently Asked Questions ### How much of OpenAI does Sam Altman own? Sam Altman holds no equity in OpenAI and earns a salary of approximately $76,000 per year from the company he leads. His wealth comes from his personal venture portfolio, not from OpenAI ownership. ### What is Sam Altman's net worth in 2026? As of 2026, Sam Altman's net worth is estimated at more than $3.3 billion, built through early-stage angel investments in companies like Reddit, Airbnb, and Stripe, plus nine-figure concentrated bets in Helion Energy and Retro Biosciences. ### What is Sam Altman's biggest personal investment? Helion Energy, where Altman holds roughly a third of the nuclear fusion startup at a $15.5 billion valuation, is his largest disclosed personal stake. He also invested $180 million of his own money in Retro Biosciences, which focuses on cellular reprogramming to extend human lifespans. ### Did Sam Altman invest in brain-computer interfaces? Yes. In January 2026, Altman co-founded Merge Labs, a brain-computer interface startup that received a $252 million investment from OpenAI, expanding his bets on deep-tech frontier categories. ### When is OpenAI's IPO? OpenAI has publicly targeted a 2027 window for its initial public offering. The company reached $20 billion in annualized revenue in mid-2026 and secured a $520 million Sora credit line in July 2026, in preparation for a public market debut. --- Original analysis from [startuphub.ai](https://www.startuphub.ai), the #1 AI startup directory.